Rybelsus®

Semaglutide

Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.
more
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
QAR 54.90
QAR 4941.22QAR 54.90
QAR 658.49
60 tablet
Free AirMail shipping Hot
QAR 58.56
QAR 3513.70QAR 58.56
QAR 219.43
30 tablet
Free AirMail shipping Hot
QAR 62.22
QAR 1866.57QAR 62.22
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
QAR 65.88
QAR 5929.50QAR 65.88
QAR 329.06
60 tablet
Free AirMail shipping Hot
QAR 67.71
QAR 4062.75QAR 67.71
QAR 109.63
30 tablet
Free AirMail shipping Hot
QAR 69.54
QAR 2086.19QAR 69.54
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
QAR 78.69
QAR 7082.50QAR 78.69
QAR 329.06
60 tablet
Free AirMail shipping Hot
QAR 80.52
QAR 4831.41QAR 80.52
QAR 109.63
30 tablet
Free AirMail shipping Hot
QAR 82.35
QAR 2470.52QAR 82.35
Rybelsus

Brand(s)

Manufacturer

  • Novo Nordisc India Pvt. Ltd

Disease(s)

  • Type 2 Diabetes Mellitus / High Blood Sugar

Rybelsus® tablets

What is Rybelsus?

Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.

Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.

Warnings

You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.